Medicare

Repeat Exam May Shed More Light on Sex Abuse (CME/CE)

(MedPage Today) -- In nearly a quarter of pediatric patients evaluated for sexual abuse or assault, a second exam turned up new information, researchers reported.

Read more...

Be the first to comment - What do you think?  Posted by MedPageToday.com - medical news plus CME for physicians - January 30, 2012 at 11:00 am

Categories: Medicaid News, Medicare   Tags: ,

Child Safety Takes a Back Seat During Carpooling (CME/CE)

(MedPage Today) -- Parents who generally have their children use booster seats in the car are not consistent in their use of booster seats when carpooling, researchers found.

Read more...

Be the first to comment - What do you think?  Posted by MedPageToday.com - medical news plus CME for physicians - January 29, 2012 at 9:01 pm

Categories: Medicaid News, Medicare   Tags: ,

Big BP Variation Between Arms Raises Red Flag (CME/CE)

(MedPage Today) -- A substantial difference in blood pressure from one arm to the other could be a warning sign for overall cardiovascular and mortality risk, a meta-analysis determined.

Read more...

Be the first to comment - What do you think?  Posted by MedPageToday.com - medical news plus CME for physicians - at 3:30 pm

Categories: Medicaid News, Medicare   Tags: ,

Troubled Cath Lab Lands Certification

(MedPage Today) -- A year ago, Excela Heath in Greensburg, Pa., was the center of an overstenting controversy. Today, its cath lab has achieved accreditation, even as new overstenting allegations surface in a neighboring area of Pennsylvania.

Read more...

Be the first to comment - What do you think?  Posted by MedPageToday.com - medical news plus CME for physicians - at 2:30 pm

Categories: Medicaid News, Medicare   Tags: ,

Viagra Shrinks Lymphatic Growths in Three Children

(MedPage Today) -- Sildenafil (Viagra) appears to lessen severe lymphatic malformations in children, according to researchers who have used the drug successfully in three pediatric patients.

Read more...

Be the first to comment - What do you think?  Posted by MedPageToday.com - medical news plus CME for physicians - at 8:10 am

Categories: Medicaid News, Medicare   Tags: ,

Combined Therapy Results Mixed in High-Risk Head, Neck Cancer

PHOENIX (MedPage Today) -- Adding chemotherapy to radiation therapy failed to improve disease control or survival in patients with high-risk head and neck cancer, long-term follow-up of a randomized trial showed.

Read more...

Be the first to comment - What do you think?  Posted by MedPageToday.com - medical news plus CME for physicians - January 27, 2012 at 3:31 pm

Categories: Medicaid News, Medicare   Tags: ,

White House: Don’t Scrap ACA If Mandate Thrown Out

WASHINGTON (MedPage Today) -- If the Supreme Court rules that the Affordable Care Act's individual mandate is unconstitutional, the entire law doesn't need to be thrown out, lawyers for the Obama administration argued in a brief filed Friday with the h...

Read more...

Be the first to comment - What do you think?  Posted by MedPageToday.com - medical news plus CME for physicians - at 3:18 pm

Categories: Medicaid News, Medicare   Tags: ,

Medicare Overpaid Billions in 2010, GAO Says

WASHINGTON (MedPage Today) -- The U.S. government overpaid private insurance companies administering Medicare Advantage plans by as much as $3.1 billion in 2010, according to a new report from the Government Accountability Office.

Read more...

Be the first to comment - What do you think?  Posted by MedPageToday.com - medical news plus CME for physicians - at 3:11 pm

Categories: Medicaid News, Medicare   Tags: ,

New Psoriasis Guidelines Expand Treatment Options (CME/CE)

(MedPage Today) -- Newer biologic agents for treating moderate-to-severe plaque psoriasis can be considered for first-line use in some cases, according to new treatment guidelines from the National Psoriasis Foundation.

Read more...

Be the first to comment - What do you think?  Posted by MedPageToday.com - medical news plus CME for physicians - at 3:00 pm

Categories: Medicaid News, Medicare   Tags: ,

Once-Weekly Diabetes Treatment Gets FDA OK

WASHINGTON (MedPage Today) -- The delay is over for the diabetes drug Bydureon (exenatide extended-release), with FDA approval making it the first once-weekly treatment for type 2 disease.

Read more...

Be the first to comment - What do you think?  Posted by MedPageToday.com - medical news plus CME for physicians - at 2:22 pm

Categories: Medicaid News, Medicare   Tags: ,

« Previous PageNext Page »

SEO Powered By SEOPressor